Tendon injury and fluoroquinolone use: A systematic review

Drug Safety

Volumn 36, Issue 9, 2013, Pages 709-721

  Stephenson, Anne L ^a   Wu, Wei ^b   Cortes, Daniel ^c   Rochon, Paula A ^b,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CORTICOSTEROID; FLEROXACIN; GARENOXACIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; SPARFLOXACIN; TOSUFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ACHILLES TENDINITIS; ACHILLES TENDON RUPTURE; COCHRANE LIBRARY; EMBASE; GENERAL PRACTITIONER; HUMAN; INCIDENCE; INFECTION; MEDICAL SPECIALIST; MEDLINE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY CONTROL; RATING SCALE; REVIEW; RISK; RISK FACTOR; SCORING SYSTEM; SELF REPORT; SURGEON; SYNOVITIS; SYSTEMATIC REVIEW; TENDINITIS; TENDON INJURY; TENOSYNOVITIS; CHEMICALLY INDUCED;

ANTI-BACTERIAL AGENTS; FLUOROQUINOLONES; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; TENDINOPATHY;

EID: 84890236922     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-013-0089-8     Document Type: Review

References (40)

1. Mehlhorn AJ, Brown DA. Safety concerns with fluoroquinolones. Ann Pharmacother. 2007;41(11):1859-66. (Pubitemid 350044349)
2. Beyer J, Schellong S. Bilateral plantar tendinitis during levofloxacin therapy (Review, 8 refs). Br J. Clin Pharm. 2006;61(5):609.
3. Karistinos A, Paulos LE. "Ciprofloxacin-induced" bilateral rectus femoris tendon rupture. 17(5):406-7.
4. Braun D, Petitpain N, Cosserat F, Loeuille D, Bitar S, Gillet P, et al. Rupture of multiple tendons after levofloxacin therapy. Revue du Rhumatisme. 2004;71(6):586-7. (Pubitemid 39626733)
5. Burkhardt O, Kohnlein T, Pap T, Welte T. Recurrent tendinitis after treatment with two different fluoroquinolones. Scand J Infect Dis. 2004;36(4):315-6. (Pubitemid 38714189)
6. Mouzopoulos G, Stamatakos M, Vasiliadis G, Skandalakis P. Rupture of adductor longus tendon due to ciprofloxacin. Acta Ortho Belgica. 2005;71(6):743-5. (Pubitemid 43088389)
7. Khaliq Y, Zhanel GG. Musculoskeletal injury associated with fluoroquinolone antibiotics (Review, 43 refs). Clinics Plastic Surgery. 2005;32(4):495-502. (Pubitemid 43181336)
8. Ever-Silva WA, Netto Hde B, Pinto JF, Ferry FR, Neves-Motta R. Severe shoulder tendinopathy associated with levofloxacin. Braz J Infect Dis. 2012;16(4):393-5.
9. Tanne JH. FDA adds "black box" warning label to fluoroquinolone antibiotics. BMJ. 2008;337:a816.
10. Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J, et al. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs. 2002;62(1):13-59. (Pubitemid 34169425)
11. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27-72. (Pubitemid 46290553)
12. O'Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008;15(Suppl A):1A-8A. (Pubitemid 351566057)
13. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003;36(11):1404-10. (Pubitemid 36702874)
14. Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med. 2005;118:259-68. (Pubitemid 40312637)
15. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
16. Costa SM, Martins CC, Bonfim MC, Zina LG, Paiva SM, Pordeus IA, et al. A systematic review of socioeconomic indicators and dental caries in adults. Int J Environ Res Public Health. 2012;9:3540-74.
17. Wise BL, Peloquin C, Choi H, Lane NE, Zhang Y. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Amer J Med. 2012;125(12):1228.e23-8.
18. Lapi F, Tuccori M, Motola D, Pugi A, Vietri M, Montanaro N, et al. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf. 2010;33(9):789-99.
19. Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf. 2006;15(11):784-92. (Pubitemid 44762709)
20. Corrao G, Zambon A, Bertu L, Mauri A, Paleari V, Rossi C, et al. Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study. Drug Saf. 2006;29(10):889-96. (Pubitemid 44511589)
21. van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HM, Rowlands S, Stricker BH. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med. 2003;163(15):1801-7. (Pubitemid 36960927)
22. Leone R, Venegoni M, Motola D, Moretti U, Piazzetta V, Cocci A, et al. Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three Italian regions. Drug Saf. 2003;26(2):109-20. (Pubitemid 36188561)
23. Chhajed PN, Plit ML, Hopkins PM, Malouf MA, Glanville AR. Achilles tendon disease in lung transplant recipients: association with ciprofloxacin. Eur Respir J. 2002;19(3):469-71. (Pubitemid 34256961)
24. van der Linden PD, Sturkenboom MC, Herings RM, Leufkens HG, Stricker BH. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ. 2002;324(7349):1306-7. (Pubitemid 34606771)
25. van der Linden PD, van Puijenbroek EP, Feenstra J, Veld BA, Sturkenboom MC, Herings RM, et al. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum. 2001;45(3):235-9. (Pubitemid 32952902)
26. van der Linden PD, Nab HW, Simonian S, Stricker BH, Leufkens HG, Herings RM. Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands (Review, 23 refs). Pharm World Sci. 2001;23(3):89-92. (Pubitemid 32607017)
27. Pierfitte C, Royer RJ. Tendon disorders with fluoroquinolones. Therapie. 1996;51(4):419-20. (Pubitemid 26300913)
28. Hori K, Yamakawa K, Yoshida N, Ohnishi K, Kawakami J. Detection of fluoroquinolone-induced tendon disorders using a hospital database in Japan. Pharmacoepidemiol Drug Saf. 2012;21:886-9.
29. Barge-Caballero E, Crespo-Leiro MG, Paniagua-Martin MJ, Muniz J, Naya C, Bouzas-Mosquera A, et al. Quinolone-related Achilles tendinopathy in heart transplant patients: incidence and risk factors. J Heart Lung Transpl. 2008;27(1):46-51.
30. Sode J, Obel N, Hallas J, Lassen A. Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol. 2007;63(5):499-503. (Pubitemid 46569916)
31. van der Linden PD, van de Lei J, Nab HW, Knol A, Stricker BH. Achilles tendinitis associated with fluoroquinolones. Br J Clin Pharmacol. 1999;48(3):433-7. (Pubitemid 29417729)
32. Wilton LV, Pearce GL, Mann RD. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol. 1996;41(4):277-84. (Pubitemid 26114816)
33. Le Huec JC, Schaeverbeke T, Chauveaux, Rivel J, Dehais J, Le Rebeller A. Epicondylitis after treatment with fluoroquinolone antibiotics. J Bone Joint Surg Br. 1995;77(293):295.
34. Schwald N, Debray-Meignan S. Suspected role of ofloxacin in a case of arthralgia, myalgia, and multiple tendinopathy. Revue du Rhumatisme. 1999;66:419-21.
35. Williams RJ III, Attia E, Wickiewicz TL, Hannafin JA. The effect of ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med. 2000;28(3):364-9. (Pubitemid 30394760)
36. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673-87. (Pubitemid 35283958)
37. Pouzaud F, Bernard-Beaubois K, Thevenin M, Warnet JM, Hayem G, Rat P. In vitro discrimination of fluoroquinolones toxicity on tendon cells: involvement of oxidative stress. J Pharmacol Exp Ther. 2004;308(1):394-402. (Pubitemid 38090742)
38. Maffulli N, Sharma P, Luscombe KL. Achilles tendinopathy: aetiology and management. J R Soc Med. 2004;97(10):472-6. (Pubitemid 39424603)
39. McLauchlan GJ, Handoll HH. Interventions for treating acute and chronic Achilles tendinitis. Cochrane Database Syst Rev 2001;(2):CD000232.
40. Marie I, Delafenetre H, Massy N, Thuillez C, Noblet C, et al. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature. Arthritis Rheum. 2008;59(3):367-72. (Pubitemid 351399207)